Print

The Children’s Oncology Group is the most experienced organization in the world in clinical development of new therapeutics for children with cancer. A dedicated network of up to 21 institutions provides the necessary infrastructure for the conduct of pediatric phase 1 trials and pharmacokinetic studies. Our experienced investigators have in-depth experience in the design and conduct of early phase cancer trials in children, with the ability to deliver data to support regulatory submissions in a time and cost effective manner. Courtesy of Wayne State University

The COG drug development experience extends into phase 2 trials. Given how rare childhood cancers are, the COG network is a proven mechanism to accrue eligible subjects to clinical trials of promising new therapies. COG offers the ability to leverage an existing remote data entry system, or to work directly with industry sponsors or CROs. The COG has a proven track record of delivering results that matter.

Phase 3 trials require thorough, extensive planning. Given the potential number of subjects required for such studies, such planning often begins several years before initiation of a study. Prioritization of potential phase 3 studies is undertaken by a national or international group of leading childhood cancer specialists and scientists. For these, reasons, it is critically important to engage with COG whenever considering the need to explore a phase 3 trials in children with cancer. COG is there to not only partner, but to provide in depth guidance in childhood cancer study development.

To learn more, email COG Industry Sponsored Trials Program (IST) at This email address is being protected from spambots. You need JavaScript enabled to view it.  or call (626) 241-1512. The Children’s Oncology Group – The world’s childhood cancer experts.

 

© The Children's Oncology Group
The information and content provided on this website is made available for informational purposes only for children and their families affected by cancer. While the Children's Oncology Group strives to provide accurate and up-to-date information, the information may be out of date or incomplete in certain respects. Please do not rely on this information and seek the care of a qualified medical professional if you have questions regarding a specific medical condition, disease, diagnosis or symptom. The information and content presented herein is not intended to replace the independent clinical judgement, medical advice, screening, health counseling, or other intervention performed by your (or your child's) health care provider. Please contact "911" or your emergency services if this is a health emergency. No endorsement of any specific tests, products, or procedures is made herein.